文献速递垂体与肾上腺疾病

肾上腺静脉取血中的对侧抑制预测原发性醛固酮增多症的临床与生化结局

Contralateral Suppression in Adrenal Venous Sampling Predicts Clinical and Biochemical Outcome in Primary Aldosteronism.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

该回顾性研究评估150例在促肾上腺皮质激素刺激下进行肾上腺静脉取血的原发性醛固酮增多症患者,分析激素参数对侧化的预测价值。对侧抑制(CS)>50%预测对侧侧化的灵敏度86.84%、特异度92.96%,且与完全生化治愈(OR 125)和高血压缓解(OR 12.19)独立相关。CS>50%患者术后生化性低醛固酮血症更常见(70% vs 16.67%,P=0.014)。

要点

  • 对侧抑制>50%预测对侧侧化的灵敏度86.84%、特异度92.96%。
  • 对侧抑制>50%与完全生化治愈(OR 125)和高血压缓解(OR 12.19)独立相关。
  • 对侧抑制>50%患者术后生化性低醛固酮血症更常见(70% vs 16.67%,P=0.014)。

核心结论

  • 对侧抑制>50%是完全临床和生化治愈的独立预测因素,并可预测单侧原发性醛固酮增多症和术后生化性低醛固酮血症。

研究设计与样本

  • 回顾性评估150例在促肾上腺皮质激素输注下连续进行肾上腺静脉取血的原发性醛固酮增多症患者。
  • 双侧成功插管率83.3%(n=140),其中双侧47.9%、单侧52.1%。

主要发现

  • 非优势侧相对醛固酮分泌指数(RASI)<0.5(即对侧抑制>50%)预测对侧侧化的灵敏度86.84%、特异度92.96%。
  • 优势侧肾上腺静脉醛固酮/皮质醇比值>5.9预测同侧侧化的灵敏度74.67%、特异度80%;优势侧RASI>4.7的灵敏度35.21%、特异度88.06%。
  • 对侧抑制>50%患者完全生化治愈率98.41% vs 42.86%(P<0.001),完全临床治愈率41.94% vs 0%(P<0.001)。
  • 对侧抑制与诊断时高醛固酮水平相关(P<0.001),与术后1个月低醛固酮水平相关(P=0.019)。
  • 术后生化性低醛固酮血症在对侧抑制>50%患者中更常见(70% vs 16.67%,P=0.014)。

关键数值与推荐

  • 多变量分析:对侧抑制>50%与完全生化治愈相关(OR 125,95%CI 11.904-5000;P=0.001)。
  • 多变量分析:对侧抑制>50%与高血压缓解相关(OR 12.19,95%CI 2.074-250;P=0.023)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The role of hormone parameters at adrenal venous sampling (AVS) in predicting clinical and biochemical outcomes remains controversial. OBJECTIVE: To investigate the impact of hormone parameters at AVS under cosyntropin stimulation on lateralization and on complete biochemical and clinical outcomes. METHODS: We retrospectively evaluated 150 sequential AVS under cosyntropin infusion. The bilateral successful cannulation rate was 83.3% (n = 140), 47.9% bilateral and 52.1% unilateral. The lateralization index, aldosterone/cortisol ratio (A/C) in the dominant adrenal vein (AV), and relative aldosterone secretion index (RASI = A/C in AV divided by A/C in inferior vena cava) were assessed. The contralateral suppression (CS) percentage was defined by (1 - nondominant RASI) * 100. RESULTS: A nondominant RASI <0.5 (CS >50%) had 86.84% sensitivity and 92.96% specificity to predict contralateral lateralization. An A/C ratio in dominant AV >5.9 (74.67% sensitivity and 80% specificity) and dominant RASI >4.7 (35.21% sensitivity and 88.06% specificity) had the worst performance to predict ipsilateral lateralization. Complete biochemical and clinical cure was significantly more frequent in the patients with CS >50% [98.41% vs 42.86% (P < .001) and 41.94% vs 0% (P < .001)]. CS correlated with high aldosterone at diagnosis (P < .001) and low postoperative aldosterone levels at 1 month (P = .019). Postoperative biochemical hypoaldosteronism was more frequent in patients with CS >50% (70% vs 16.67%, P = .014). In multivariable analysis, a CS >50% was associated with complete biochemical cure [odds ratio (OR) 125, 95% confidence interval (CI) 11.904-5000; P = .001] and hypertension remission (OR 12.19, 95% CI 2.074-250; P = .023). CONCLUSION: A CS >50% was an independent predictor of complete clinical and biochemical cure. Moreover, it can predict unilateral primary aldosteronism and postoperative biochemical hypoaldosteronism. Our findings underscore the usefulness of CS for clinical decision-making.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Okubo J, Frudit P, Cavalcante ACBS, et al. Contralateral Suppression in Adrenal Venous Sampling Predicts Clinical and Biochemical Outcome in Primary Aldosteronism. J Clin Endocrinol Metab. 2024. PMID: 38442744. doi:10.1210/clinem/dgae142

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。